Hepatitis C: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• AKT 0
• IL-17 0
• PD-L1 0
• PNPLA3 0
• PPAR 0
• TP53 0
• VEGF 0
• HMGB1 0
• IL-6 0
• mTOR 0
• PI3K 0
• YAP 0
• ATM 0
• BCL-2 0
• CD19 0
• CD40 0
• CTLA-4 0
• CTNNB1 0
• DPP-4 0
• ERK 0
• FAK 0
• GPC3 0
• HDAC 0
• HIF-1 0
• HSP90 0
• IDH 0
• IL-1 0
• IL-23 0
• NLRP3 0
• NRAS 0
• PCSK9 0
• PD-1 0
• PTEN 0
• SGLT2 0
• STAT3 0
• TNF 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  Single-molecule Nanopore Analysis Platform for RNA Readout (SNAPRR)

  The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin· Dublin, Írország· EU contribution 1 670 246 EUR· until 2031. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  Ravidasvir to combat the emergence and spread of artemisinin resistance in Africa: a phase 2 and 3 clinical trial to assess its efficacy (RAMP)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 10 298 969 EUR· until 2031. aug.· 6 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Non-canonical modification of viral RNA (MOVIRNA)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 1 996 986 EUR· until 2029. jún.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer.

  Alma Mater Studiorum - Universita di Bologna· Bologna, Olaszország· EU contribution 5 801 578 EUR· until 2027. ápr.· 7 countries

• European Commission (Horizon 2020) · ERC-ADG

  Targeted strategies for prevention and treatment of fibrosis-associated liver cancer (FIBCAN)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 2 430 000 EUR· until 2028. jún.· 2 countries

5 of 5 running projects, newest first. Listed amounts together: 22,2 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 3
• Mendelian Randomization Analysis 5
• CRISPR-Cas Systems 9
• Gene Expression Profiling 12
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 4
• Proteomics 5
• Metabolomics 3
• Mass Spectrometry 1
• Flow Cytometry 5
• Immunohistochemistry 8
• Positron-Emission Tomography 2
• Magnetic Resonance Imaging 7
• Machine Learning 22
• Deep Learning 2
• Cohort Studies 84
• Genome-Wide Association Study 5

• Integrating HCV Testing and Treatment Into HIV Care: A Cohort Study of the HCV Care Cascade in Southwest China.

  Liver Int, 2026. nov.

• Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study.

  Hepatol Commun, 2026. okt.

• Optimizing the HCV Care Continuum in Primary Care: Opportunistic Screening With Point-Of-Care RNA Testing and Immediate Linkage-To-Care in Rio de Janeiro, Brazil.

  J Viral Hepat, 2026. okt.

• Linking Military Blast Exposure to Veterans Health Administration Diagnoses: Chronic Health Outcomes in the Millennium Cohort Study.

  Neurology, 2026. szept.

• An Exploratory Intersectional Analysis of Lifetime Syphilis Prevalence Among People Who Inject Drugs in Montreal, Canada.

  Sex Transm Dis, 2026. szept.

• Pre-ART Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio and the Risk of Non-AIDS-events, AIDS-Events, and Mortality in People With HIV.

  J Acquir Immune Defic Syndr, 2026. szept.

• Developing a Preterm Birth Prediction Model in Pregnant People With HIV Using a Population-Based Cohort.

  J Acquir Immune Defic Syndr, 2026. szept.

• Viral seropositivity in a Brazilian cohort of patients with multiple sclerosis: A retrospective descriptive study.

  J Neurol Sci, 2026. aug.

• Persisting disparities in hepatitis B diagnoses, associated risk factors, and time to diagnosis among migrants compared with Danish-born populations: a matched cohort study.

  Eur J Public Health, 2026. aug.

• Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort.

  Mil Med, 2026. aug.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.